Products

MeetingAutopsy

AI-native

Your meetings are dying. Find out why.

meeting-autopsy.vercel.app Productivity & Collaboration / Meetings & Note-Takers

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$7/mo
Lower than 82% of peersNiche median $14/mo
Creators
Talha Aftab
No social account linked
Launched
6mo ago
2026-05-18 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    AI post-mortem for bad meetings. Score, diagnose, fix.

    May 18 · 6mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2020-01-28

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Free
Free
3 autopsies per month
Pro
$7/mo

Trial: None · Free tier included · 1 paid tier ($7) · Observed 2026-11-08 · Pricing page

Entry price $7/mo, Lower than 82% of peers; “Meetings & Note-Takers” median is $14/mo.View pricing benchmark

Website snapshots

Indexed 2026-05-18

Key pages

Desktop & mobile archive
meeting-autopsy.vercel.app/ Snapshot 2026-11-08

Questions & evidence

How much does MeetingAutopsy cost?
Free: Free; Pro: $7/mo. Observed 2026-11-08. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does MeetingAutopsy get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is MeetingAutopsy and what platforms does it support?
MeetingAutopsy is catalogued under Meetings & Note-Takers: Your meetings are dying. Find out why. Supported platforms: Web.

Related products in this category

Productivity & Collaboration / Meetings & Note-Takers

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.